home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

New procedures and innovations for analytical development of Biopharmaceuticals

 
  July 13, 2013  
     
 
Euroscicon, Cineworld: The O2
Thursday, 28 November 2013


The role of the analytical developer has always been challenging but, in recent years, with the advent of ever-higher expectations, more complex products, regulatory authority and corporate driven innovations there has been an increased need for improved techniques.   There are, of course, many ways to tackle some, if not all of these issues, with many solutions such as multimodal and multipurpose technologies arising in the last few years.  This meeting will cover these newer procedures and innovations that are being  developed and introduced to analytical development and will evaluate their applicability and potential impact to the pharmaceutical and  biotechnology industry
 
 
Organized by: Euroscicon
Invited Speakers:

Dr Iva ChianellaCranfield University

Professor Stephen Harding, University of Nottingham, UK

Dr Andrew SplevinsGroup Leader, Analytical Sciences, Syntaxin Ltd, UK

Dr Mohammed Maniruzzaman, University of Greenwich, Medway Campus 

Dr Clemens Stilling, UCB, Belgium 

 
Deadline for Abstracts: July 20th 2013
 
Registration: http://www.regonline.co.uk/analytical2013
E-mail: enquiries@euroscicon.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.